CN113082055B - Regenerated colored hair injection and preparation method thereof - Google Patents

Regenerated colored hair injection and preparation method thereof Download PDF

Info

Publication number
CN113082055B
CN113082055B CN202110400050.9A CN202110400050A CN113082055B CN 113082055 B CN113082055 B CN 113082055B CN 202110400050 A CN202110400050 A CN 202110400050A CN 113082055 B CN113082055 B CN 113082055B
Authority
CN
China
Prior art keywords
stem cells
hair
injection
epidermal stem
dmem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110400050.9A
Other languages
Chinese (zh)
Other versions
CN113082055A (en
Inventor
张甜甜
邢志青
张平
王杰
孙红
李芬
楚天云
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jinan Pantheon Biotechnology Co ltd
Original Assignee
Jinan Pantheon Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jinan Pantheon Biotechnology Co ltd filed Critical Jinan Pantheon Biotechnology Co ltd
Priority to CN202110400050.9A priority Critical patent/CN113082055B/en
Publication of CN113082055A publication Critical patent/CN113082055A/en
Application granted granted Critical
Publication of CN113082055B publication Critical patent/CN113082055B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/33Fibroblasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0625Epidermal cells, skin cells; Cells of the oral mucosa
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0625Epidermal cells, skin cells; Cells of the oral mucosa
    • C12N5/0626Melanocytes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0656Adult fibroblasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00Methods for the dissociation of cells, e.g. specific use of enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses a regenerative colored hair injection and a preparation method thereof, the method separates epidermal stem cells, melanocytes and dermal fibroblasts from scalp tissues, a cell mass formed by the melanocytes and the dermal fibroblasts and the epidermal stem cells are mixed according to a certain proportion to obtain the regenerative hair injection, and the injection is injected to a hair regeneration part to gradually regenerate the colored hair.

Description

Regenerated colored hair injection and preparation method thereof
Technical Field
The invention relates to a regenerated colored hair injection and a preparation method thereof, belonging to the field of cell engineering.
Background
Alopecia and poliosis are common diseases affecting men, women and children. Currently, the treatment of alopecia mainly depends on drugs and autologous hair transplantation, but the two methods have some difficulties, such as limited drug effect, incapability of increasing the hair quantity of the scalp, and the like. The formation of hair follicles during embryonic development and postnatal hair circulation is regulated by a series of interactions between epithelial-derived hair follicle stem cells (e.g., hair follicle epithelial stem cells, enlarged epithelial stem cells) and mesenchymal-derived hair follicle stem cells (e.g., dermal papilla cells, hair follicle dermal cells). Methods for maintaining this ability have been investigated, including the use of growth factors and signal molecules. For example, loss of fibroblast growth factor-2, Wnt and bone morphogenic proteins may reduce the hair-inducing ability of DP cells. Another approach is to fabricate 3D tissue prior to transplantation and increase DP cell-specific marker expression by forming aggregates of DP cells in hanging drop or non-cell-adherent culture conditions.
The white hair disease can be divided into 2 types of physiological white hair and pathological white hair, and is fundamentally caused by the disorder of the lineage balance of melanocytes in hair follicles regardless of the occurrence mechanism. During hair coloring, melanin granules secreted by melanocytes have a direct effect; once destroyed, the subsequent other progeny melanocytes will eventually lose function. Western medicine has no specific treatment to the disease at present, and the hair dyeing can induce various diseases, such as contact dermatitis, leukemia, osteoporosis, even canceration and the like. In contrast, the traditional Chinese medicine has obvious advantages for treating the disease, can adopt treatment methods such as oral administration, external washing, acupuncture and massage, medicated diet and the like, is worthy of wide application, but needs to be persisted for a long time and has different effects according to different people.
Disclosure of Invention
The invention overcomes the defects of the prior art and provides a regenerated colored hair injection and a preparation method thereof, the method separates epidermal stem cells, melanocytes and dermal fibroblasts from scalp tissues, a cell mass formed by the melanocytes and the dermal fibroblasts and the epidermal stem cells are mixed according to a certain proportion to obtain the regenerated hair injection, and the injection is injected to a hair regeneration part to gradually regenerate the colored hair.
A method for preparing an injection for regenerating colored hair comprises the following steps:
1) obtaining scalp tissues, digesting and separating primary epidermal stem cells, primary melanocytes and primary dermal fibroblasts;
2) subculturing the primary epidermal stem cells obtained in the step 1), collecting epidermal stem cells of P3-P5 generations, and inoculating the epidermal stem cells into a cell culture bottle;
3) melanocytes and dermal fibroblasts were measured in a quantitative ratio of 1: (5-20), adding a multifunctional serum-free cell culture medium for resuspension, inoculating the mixture in a low adsorption culture plate after resuspension, culturing for 2-3 days to form a 3D cell mass of melanocytes and dermal fibroblasts, collecting a 3D cell mass suspension, centrifuging, and retaining a supernatant and the centrifuged 3D cell mass;
4) mixing the epidermal stem cells collected in the step 2) and the 3D cell mass after centrifugation in the step 3) according to the quantitative ratio of (2:1) - (1:5), and using the supernatant obtained in the step 3) to resuspend the mixed cells;
5) and (3) cleaning the mixed cells obtained in the step 4) by using DMEM (DMEM) without double antibodies, centrifuging, then discarding the supernatant, and re-suspending the supernatant collected in the step 3) for precipitation, thus obtaining the regenerated colored hair injection.
Further, 8-12 mL of the epidermal cell culture medium is added into the cell culture bottle in the step 2), and the epidermal stem cells of the P3-P5 generation are inoculated into the cell culture bottle according to the bottle of 120-150 ten thousand/T75, wherein the epidermal cell culture medium is prepared according to the patent No. 201610473310.4.
Further, the multifunctional serum-free cell culture medium described in step 3) is a culture medium prepared using the method of patent No. 201610473348.1.
Further, the centrifugation in step 5) is performed at 600-.
Further, the method for separating the epidermal stem cells, the melanocytes and the dermal fibroblasts in the step 1) comprises the following steps:
s1, obtaining scalp tissue, sterilizing, placing in a mixed solution of dissociation enzyme and pancreatin, digesting at 37 ℃ for 10-120min, and neutralizing enzyme reaction by using a DMEM medium containing 10% FBS to form a neutralization solution A;
s2, blowing the neutralization solution A, and filtering the neutralization solution A through a 70-micron filter screen to obtain a filtrate A and a filter residue A;
s3 centrifuging the filtrate A at 600rpm for 4-5min to retain precipitate A;
s4, adding a collagenase I solution with the final concentration of 0.25-5.0 mg/mL into the filter residue A, digesting for 10-120min at 37 ℃, repeatedly beating for 2-60 times by using a DMEM medium containing 10% FBS, and carrying out a neutralization enzyme reaction to form a neutralization solution B;
s5 filtering the neutralization solution B through a 100-micron filter screen, reserving the filtrate B, and centrifuging the filtrate B for 4-5min at the speed of 600-1000rpm to obtain a precipitate B;
s6 the sediment A obtained in the step S3 and the sediment B obtained in the step S5 are respectively counted after being re-suspended by using DMEM culture medium, the cells obtained from the sediment A are divided into 2 parts, one part is cultured by using human skin epidermal cell culture medium, and the other part is cultured by using melanocyte culture medium; culturing the cells obtained from the pellet B using a multifunctional serum-free cell culture medium; the epidermal stem cells, the melanocytes and the dermal fibroblasts can be separated.
Further, the scalp tissue in step S1 is occipital scalp tissue including hair follicles and hair papilla portions.
Further, the sterilization method in the step S1 is: rinsing scalp tissue with DPBS for 2 times, soaking in 75% alcohol for 5min, and soaking in PBS containing streptomycin double antibody for 5min for 2 times.
Further, in the mixed solution of the dissociation enzyme and the pancreatin in the step S1, the final concentration of the dissociation enzyme is 0.5 to 5.0mg/mL, and the final concentration of the pancreatin is 0.05 to 0.5%.
Further, the collagenase i solution and the DMEM medium containing 10% FBS are used in a volume ratio of 1:1 in step S4.
Further, the multifunctional serum-free cell culture medium described in step S6 is a culture medium prepared by the method described in patent No. 201610473348.1
Further, the human epidermal cell culture medium described in step S6 is a medium prepared using the method in patent No. 201610473310.4.
Further, the Melanocyte Medium in step S6 is a TPA-free Medium, preferably one of (1) Medium 254CF available from Gibco, Melanocyte Medium M2 available from Promocell, and Melanocyte Medium-2(MelM-2) available from Sciencell.
Further, the application of the regenerated colored hair injection prepared by the preparation method in promoting the growth of colored hair.
Has the advantages that:
the technical method is simple, and the hair can be regenerated, and the regenerated hair is colored, and the color can be controlled by adjusting different cell proportions.
Drawings
FIG. 1 shows the condition of melanocytes, epidermal cells and dermal cells.
FIG. 23D photograph showing the process of cell mass formation.
FIG. 3 shows the growth of colored regrown hair in mice.
Figure 4 comparison graph of human regenerated colored hair.
Detailed Description
In order to make the technical solutions in the present application better understood, the present invention is further described below with reference to examples, which are only a part of examples of the present application, but not all examples, and the present invention is not limited by the following examples.
Example 1
Materials and procedures
1. Scalp tissue extraction and disinfection
(1) Obtaining a tissue sample: tissue origin: the scalp was discarded and the appearance of the scalp was normal. Organization requirements: when taking scalp, ensuring that the taken tissue contains hair follicle and hair papilla part;
(2) disinfection treatment of scalp group: the subcutaneous tissue was removed (removed as clean as possible) with a scalpel or scissors, washed 1 time in 70% ethanol, 5min, and the tissue was washed 5 min/2 times in PBS petri dishes containing 2 × double antibody.
2. Obtaining primary dermal epidermal stem cells and melanocytes
Placing the sterilized skin tissue in a water bath at 37 ℃ in a solution containing 3.5mg/mL of dissociation enzyme and 0.25% of pancreatin for digestion until a large number of cells fall off, wherein the digestion time is 30min, neutralizing the enzyme reaction by using a DMEM medium containing 10% FBS, repeatedly blowing and beating for more than 20 times to obtain a single cell suspension, filtering by using a 70-micron filter screen, centrifuging the filtered suspension for 5 minutes at 600rpm, cleaning once by using 10mL of 10% FBS DMEM to obtain primary skin epidermal stem cells and melanocyte suspension, counting, placing the cell suspension in a centrifuge, centrifuging for 5min at 600rpm, and reserving the cell suspension to obtain primary skin epidermal stem cells and melanocyte mixed sediment. Separating the obtained primary skin epidermal stem cell and melanocyte mixed precipitate into two parts, one part is cultured with human skin epidermal cell culture medium (patent No. 201610473310.4); and culturing the other part by using a melanocyte culture medium to obtain primary skin epidermal stem cells and melanocytes.
3. Obtaining dermal fibroblasts
After filtering the above using a 70 micron filter, the undigested tissue mass on the filter was transferred to a new centrifuge tube and digested with collagenase I at 3.5mg/mL in a water bath at 37 ℃ for 30 min. Then, 150uL of 10mg/mL DNase was added to continue the digestion for 5 min. The tissue was shaken off several times during incubation to disperse the clumped tissue. The cells were neutralized with the same volume of DMEM medium containing 10% FBS (containing double antibody), and gently beaten 20 times. Centrifuge at 1000rpm for 5 min. Resuspending the cell pellet with 10mL DMEM containing double antibody to obtain dermal fibroblast suspension, counting, centrifuging the cell suspension in a centrifuge at 1000rpm for 5min, and retaining the pellet to obtain dermal fibroblast, and culturing the obtained cell with multifunctional serum-free cell culture medium (patent No. 201610473348.1).
4. Obtaining regenerated colored hair injection
(1) When the confluence degree of the cells reaches about 80%, the cells are subjected to passage according to the ratio of 1: 2-1: 5.
(2) Culturing and subculturing the epidermal stem cells, the melanocytes and the dermal fibroblasts obtained in the steps, and selecting the dermal fibroblasts, the melanocytes and the epidermal stem cells of the generations P3-P5 to be respectively inoculated according to the following methods:
the epidermal stem cells were inoculated according to the 120-150 ten thousand/T75 flask;
according to 10 7 Dermal fibroblasts and 10 6 Mixing the melanocytes, adding a multifunctional serum-free cell culture medium for resuspension, inoculating the mixture into a 6-hole low-adsorption culture plate, culturing for 2 days, wherein the final volume of the culture medium in each hole is 3-5 mL, so that dermal fibroblasts and the melanocytes form a 3D cell mass.
(3) Collecting the suspension forming the 3D cell mass, centrifuging at 1000rpm/min for 5min, retaining the supernatant and the centrifuged cell mass, and transferring the supernatant to a new centrifuge tube for later use.
(4) After the epidermal stem cells are digested, collecting the epidermal stem cells, and mixing the collected epidermal stem cells with the centrifuged cell mass obtained in the step (1: 2, and mixing.
(5) Washing the mixed cells once by using DMEM (DMEM) without double antibodies, centrifuging for 5min at 1000rpm, discarding the supernatant, and re-suspending the cell sediment for regenerating the colored hair of the nude mouse by using 1mL of 3D culture supernatant to obtain regenerated colored hair injection; the cell sediment for regenerating colored hair on the head of a human body is resuspended by using 5mL of 3D culture supernatant, and then the regenerated colored hair injection can be obtained.
5. Results
As shown in FIG. 1, A in FIG. 1 is a passaged melanocyte, which is a spindle-shaped bipolar cell with branches; b in FIG. 1 is human dermal fibroblast cells in the shape of an elongated spindle, like a fibroblast, with an oval nucleus; in FIG. 1, C is an epidermal cell which is typically in the shape of a paving stone, has clear intercellular spaces, can obviously distinguish adjacent regions, has better refractive index, and has clear cytoplasm without impurities.
As shown in FIG. 2, A in FIG. 2 is a state where 3D culture cell suspension was inoculated into a 6-well low adsorption plate, and cells were individually dispersed in the culture solution; b in FIG. 2 is a state that 3D culture cell suspension is inoculated to a 6-well low-adsorption culture plate for 6h, cells begin to agglomerate, the cell agglomerates are small, and the cells are irregular; in fig. 2, C is the state that the 3D culture cell suspension is inoculated to the 6-well low-adsorption culture plate for 24 hours, and the cell mass begins to become larger and takes an irregular shape; in FIG. 2, D is the state that the 3D culture cell suspension is inoculated to the 6-well low-adsorption culture plate for 48h, the cell mass is large, and the cell mass is in a more regular circular shape.
EXAMPLE 2 regeneration of colored Hair in nude mice
1. Preparation of injection
(1) Regenerated colored hair injection a was prepared according to the preparation method in example 1.
(2) Preparation of regenerated colored Hair injection B, injection preparation according to the method in example 1, in step (2) according to 10 7 Dermal fibroblast and 2X 10 6 Mixing the melanocytes, adding a multifunctional serum-free cell culture medium for resuspension, inoculating the mixture into a 6-hole low-adsorption culture plate, culturing for 2 days, wherein the final volume of the culture medium in each hole is 3-5 mL, so that the dermal fibroblasts and the melanocytes form a 3D cell mass.
(3) Preparation of regenerated colored Hair injection C, injection C was prepared according to the method of example 1, and 10 was inoculated in step (2) 7 Adding a multifunctional serum-free cell culture medium into each dermal fibroblast, carrying out resuspension, inoculating the dermal fibroblast into a 6-hole low-adsorption culture plate, and culturing for 2 days, wherein the final volume of the culture medium in each hole is 3-5 mL, so that the dermal fibroblast forms a 3D cell mass.
(4) Male nude mice, 9, were selected at 6-8 weeks, divided into 3 groups, 3/group: injection a was used in test group 1, injection B was used in test group 2, and injection C was used in test group 3.
2. Method for using injection
(1) Anaesthetizing the nude mice to be transplanted, and injecting the injection of each test group to the back of the nude mice by microneedle injection or other methods;
(2) coating a small amount of antibacterial ointment around the wound, and bandaging the wound with an elastic bandage;
(3) after 10 days of operation, the gauze was removed and hair formation was continued (3-6 months).
3. Results of the experiment
A in FIG. 3 uses a 3D cell mass formed with dermal fibroblasts only (test)Group 3) the hair regenerated after being mixed and injected with the epidermal stem cells according to a certain proportion has more white hair; b in fig. 3 uses 10 7 Dermal fibroblasts and 10 6 The 3D cell mass formed by the melanocytes (test group 1) and the epidermal stem cells are mixed and injected according to a certain proportion, and a small amount of white hair exists in the regenerated hair; c in FIG. 3 uses 10 7 Dermal fibroblast and 2X 10 6 The 3D cell mass (test group 2) formed by the individual melanocytes was mixed with epidermal stem cells at a certain ratio and injected to regenerate black hair.
Example 3 regeneration of colored Hair
1. Preparation of injection
Injection D and injection E from example 2 were prepared according to the procedure in example 2, injection D containing 2X 10 7 Dermal fibroblast and 4X 10 6 Mixing with melanocytes, and making injection E containing 2 × 10 7 Dermal fibroblasts.
2. Application method
The injection D and the injection E are respectively injected into the hair-missing part by microneedle injection or other methods.
Firstly, determining a part of a patient needing to regenerate colored hair, taking a comfortable body position and taking the part as a center, circularly disinfecting skin from inside to outside, and taking the condition that the disinfection radius covers the area needing to regenerate the colored hair as the standard;
secondly, exposing a regeneration area, and injecting the effective anesthetic into a part with less hair to be regenerated by using a micro needle injection method or other methods;
③ other treatments after injection.
3. Results of the experiment
After 4 months, the gradual regrowth of colored hair was observed (see FIG. 4).
In fig. 4, a, the number of hairs regenerated after the 3D cell mass formed only by the dermal fibroblasts and the epidermal stem cells are mixed according to a certain ratio (injection E) is small, and the hairs are all white hairs; b in FIG. 4 is 2X 10 7 Dermal fibroblasts and 4X 10 6 3D cell formed by melanocyteThe hair regenerated after the ball and the epidermal stem cells are mixed according to a certain proportion (injection D) is more, and the hair is black.

Claims (7)

1. The preparation method of the injection for regenerating colored hair is characterized by comprising the following steps:
1) obtaining scalp tissues, digesting and separating primary epidermal stem cells, primary melanocytes and primary dermal fibroblasts, and specifically comprising the following steps:
s1: obtaining scalp tissue, sterilizing, placing in mixed solution of dissociation enzyme and pancreatin, digesting at 37 deg.C for 10-120min, and neutralizing enzyme reaction with DMEM medium containing 10% FBS to form neutralized solution A; the final concentration of the dissociation enzyme in the mixed solution of the dissociation enzyme and the pancreatin is 0.5-5.0 mg/mL, and the final concentration of the pancreatin is 0.05% -0.5%; the scalp tissue is occipital scalp tissue containing hair follicles and hair papilla parts;
s2: blowing the neutralization solution A, and filtering the neutralization solution A through a 70-micrometer filter screen to obtain a filtrate A and filter residue A;
s3: centrifuging the filtrate A at 600rpm for 4-5min, and retaining precipitate A;
s4: adding collagenase I solution with the final concentration of 0.25-5.0 mg/mL into the filter residue A, digesting for 10-120min at 37 ℃, repeatedly beating for 2-60 times by using a DMEM (DMEM) culture medium containing 10% FBS, and carrying out a neutralization enzyme reaction to form a neutralization solution B;
s5: filtering the neutralization solution B by a filter screen of 100 mu m, reserving the filtrate B, and centrifuging the filtrate B for 4-5min by using 600-1000rpm to obtain a precipitate B;
s6 the sediment A obtained in the step S3 and the sediment B obtained in the step S5 are respectively counted after being re-suspended by using DMEM culture medium, the cells obtained from the sediment A are divided into 2 parts, one part is cultured by using human skin epidermal cell culture medium, and the other part is cultured by using melanocyte culture medium; culturing the cells obtained from the pellet B using a multifunctional serum-free cell culture medium; the epidermal stem cells, the melanocytes and dermal fibroblasts can be separated;
2) subculturing the primary epidermal stem cells obtained in the step 1), collecting epidermal stem cells of P3-P5 generations, and inoculating the epidermal stem cells into a cell culture bottle;
3) melanocytes and dermal fibroblasts were measured in a quantitative ratio of 1: (5-20), adding a multifunctional serum-free cell culture medium for resuspension, inoculating the cells into a culture plate after resuspension, culturing for 2-3 days to form a 3D cell mass of melanocytes and dermal fibroblasts, collecting a 3D cell mass suspension, centrifuging, and reserving a supernatant and the centrifuged 3D cell mass;
4) mixing the epidermal stem cells collected in the step 2) and the 3D cell masses centrifuged in the step 3) according to the number ratio of (2:1) - (1:5), and re-suspending the mixed cells by using the supernatant obtained in the step 3);
5) and (3) cleaning the mixed cells obtained in the step 4) by using DMEM (DMEM) without double antibody, centrifuging, then discarding the supernatant, and re-suspending the precipitate by using the supernatant collected in the step 3) to obtain the regenerated colored hair injection.
2. The method as set forth in claim 1, wherein 8-12 mL of the epidermal cell culture medium is added into the cell culture flask in step 2), and the epidermal stem cells of the P3-P5 generation are inoculated into the cell culture flask according to the 120-150 ten thousand/T75 flask.
3. The method according to claim 1, wherein the centrifugation in step 5) is performed at 600-1000rpm for 5 min.
4. The method of claim 1, wherein the sterilizing step S1 is performed by: rinsing scalp tissue with DPBS for 2 times, soaking in 75% ethanol for 5min, and soaking in PBS containing streptomycin double antibody for 5min for 2 times.
5. The method according to claim 1, wherein the collagenase i solution and the DMEM medium containing 10% FBS are used in a volume ratio of 1:1 in step S4.
6. The method according to claim 1, wherein the melanocyte medium according to step S6 is a medium containing no TPA component.
7. Use of an injection for regenerating colored hair prepared by the preparation method according to any one of claims 1 to 6 for promoting the growth of colored hair.
CN202110400050.9A 2021-04-14 2021-04-14 Regenerated colored hair injection and preparation method thereof Active CN113082055B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110400050.9A CN113082055B (en) 2021-04-14 2021-04-14 Regenerated colored hair injection and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110400050.9A CN113082055B (en) 2021-04-14 2021-04-14 Regenerated colored hair injection and preparation method thereof

Publications (2)

Publication Number Publication Date
CN113082055A CN113082055A (en) 2021-07-09
CN113082055B true CN113082055B (en) 2022-09-06

Family

ID=76677578

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110400050.9A Active CN113082055B (en) 2021-04-14 2021-04-14 Regenerated colored hair injection and preparation method thereof

Country Status (1)

Country Link
CN (1) CN113082055B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110343755A (en) * 2018-04-03 2019-10-18 伽蓝(集团)股份有限公司 A kind of screening adjusts the method and its application of skin pigment active matter
CN110699316A (en) * 2019-10-29 2020-01-17 济南磐升生物技术有限公司 A method for preparing cell suspension for promoting hair regeneration and preventing alopecia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103502440B (en) * 2011-02-24 2016-06-29 株式会社器官再生工学 The in check transplanting of hair color regenerates the manufacture method of the former base of hair follicle, comprises the compositions of the transplanting regeneration former base of hair follicle and the implantation method of the regeneration former base of hair follicle
CN103785064B (en) * 2013-08-26 2015-02-25 济南磐升生物技术有限公司 Human skin module and application thereof
CN104548209B (en) * 2015-02-03 2017-01-25 苏州磐升生物技术有限公司 Tissue-engineered epidermis and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110343755A (en) * 2018-04-03 2019-10-18 伽蓝(集团)股份有限公司 A kind of screening adjusts the method and its application of skin pigment active matter
CN110699316A (en) * 2019-10-29 2020-01-17 济南磐升生物技术有限公司 A method for preparing cell suspension for promoting hair regeneration and preventing alopecia

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
一种分离人表皮角质形成细胞的新方法;邹德波等;《临床皮肤科杂志》;20160605;第45卷(第6期);全文 *

Also Published As

Publication number Publication date
CN113082055A (en) 2021-07-09

Similar Documents

Publication Publication Date Title
US9999589B2 (en) Culture medium of adipose-derived stem cell, method for preparing the same, and composition including the same for promoting hair growth
CN102027106B (en) Methods for producing hair microfollicles and de novo papillae and their use for in vitro tests and in vivo implantations
KR101854490B1 (en) Method of preparing regenerated hair follicle germ for transplantation in which hair color is controlled, composition including regenerated hair follicle germ for transplantation, and method of transplanting regenerated hair follicle germ
CN108992466B (en) Preparation method of injection for treating androgenetic alopecia by using hair papilla cell exosomes
CN113046316B (en) M2 type bone marrow macrophage exosome, application thereof and spinal cord injury treatment preparation
CN101748096A (en) Sub totipotential stem cell and preparation method and application thereof
CN110079503A (en) Immortalised stem cell, preparation method, the pharmaceutical composition and pharmaceutical preparation that Ji Yiqi product is effective component
CN106659741B (en) Hair growth promoting function of small-sized stem cells and use thereof
CN101541954A (en) Use of a composition contaning human umbilical cord blood-derived mesenchymal stem cell for inducing differentiation and proliferation of neural precursor cells or neural stem cells to neural cells
Reynolds et al. Cultured human and rat tooth papilla cells induce hair follicle regeneration and fiber growth
CN113134015A (en) Extracellular vesicles and use thereof in skin products
US20110305671A1 (en) Cell Compositions and Methods for Hair Follicle Generation
KR102104120B1 (en) 3D bioprinting construct using human nasal inferior turbinate derived mesenchymal stem cell and uses thereof
CN110699316A (en) A method for preparing cell suspension for promoting hair regeneration and preventing alopecia
JP2022031757A (en) Method for production of hair follicles and de novo papillae, and use thereof for in vitro tests and in vivo implants
CN108619169A (en) A kind of mesenchymal stem cell injection and preparation method for treating cerebral arterial thrombosis
CN108324993B (en) Stem cell complex for inducing hair regeneration, preparation method and application thereof
CN113082055B (en) Regenerated colored hair injection and preparation method thereof
CN114672456A (en) Method for improving extracellular vesicle secretion efficiency of adipose-derived stem cells by utilizing ultrasonic stimulation and application
KR101635148B1 (en) Pharmaceutical composition for promoting treatment of parkinson's disease comprising neural cell and elistin like polypeptide
RU2428996C2 (en) Biotransplant for correction of soft tissue defects (versions), method of biotransplant obtaining (versions) and method of correction of soft tissue defects
CN106399318A (en) Method for modifying cells by virtue of oxygen-regulated basic fibroblast growth factor
AU2020103546A4 (en) A hair follicle microarray co-isolation system and its application in the treatment of pathological hair loss
CN112300982B (en) Hair follicle microarray co-culture system and application thereof in medicine for treating pathological alopecia
CN106591222A (en) Method for extracting active components of skin stem cells

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant